Wellspring Financial Advisors’s Boston Scientific BSX Stock Holding History

Wellspring Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,073	Closed	-$1.15M	–	286
2025 Q4	$1.15M	Buy	+12,073	New	+$1.18M	0.09%	74
2025 Q3	–	Sell	-2,808	Closed	-$302K	–	181
2025 Q2	$302K	Buy	+2,808	New	+$284K	0.03%	110

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellspring Financial Advisors's BSX Position: Q1 2026 in Review

Wellspring Financial Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 12,073 shares — an estimated $1.15M sold.

Wellspring Financial Advisors first reported a position in BSX in Q2 2025 and held it in 2 quarters. The position peaked at $1.15M in Q4 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Wellspring Financial Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Wellspring Financial Advisors sold 12,073 Boston Scientific shares in Q1 2026, an estimated $1.15M.
Wellspring Financial Advisors first reported a position in Boston Scientific in Q2 2025 and held it in 2 quarters.
Wellspring Financial Advisors's Boston Scientific position peaked at $1.15M in Q4 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wellspring Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.